Wnt/β-catenin signaling in cancers and targeted therapies

F Yu, C Yu, F Li, Y Zuo, Y Wang, L Yao, C Wu… - … and Targeted Therapy, 2021 - nature.com
Wnt/β-catenin signaling has been broadly implicated in human cancers and experimental
cancer models of animals. Aberrant activation of Wnt/β-catenin signaling is tightly linked with …

Clinical actionability of molecular targets in endometrial cancer

ME Urick, DW Bell - Nature Reviews Cancer, 2019 - nature.com
Abstract Endometrial cancer accounts for~ 76,000 deaths among women each year
worldwide. Disease mortality and the increasing number of new diagnoses make …

Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy

A León-Castillo, SM De Boer, ME Powell… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE The randomized Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in
Women With High-Risk Endometrial Cancer (PORTEC-3) trial investigated the benefit of …

[HTML][HTML] Proteogenomic characterization of endometrial carcinoma

Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang… - Cell, 2020 - cell.com
We undertook a comprehensive proteogenomic characterization of 95 prospectively
collected endometrial carcinomas, comprising 83 endometrioid and 12 serous tumors. This …

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

L Vermij, JJ Jobsen, A León-Castillo… - British journal of …, 2023 - nature.com
Background Risk-assessment of endometrial cancer (EC) is based on clinicopathological
factors and molecular subgroup. It is unclear whether adding hormone receptor expression …

Clinical and molecular characterization of early‐onset colorectal cancer

AN Willauer, Y Liu, AAL Pereira, M Lam, JS Morris… - Cancer, 2019 - Wiley Online Library
Background Colorectal cancer (CRC) incidence is increasing in adults younger than 50
years. This study evaluated clinical and molecular features to identify those features unique …

Incorporation of molecular characteristics into endometrial cancer management

L Vermij, V Smit, R Nout, T Bosse - Histopathology, 2020 - Wiley Online Library
Histopathological evaluation including subtyping and grading is the current cornerstone for
endometrial cancer (EC) classification. This provides clinicians with prognostic information …

Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)

WG McCluggage, N Singh, CB Gilks - Histopathology, 2022 - Wiley Online Library
An updated World Health Organization (WHO) classification of female genital tumours was
published in autumn 2020. We discuss the major new additions to and changes from the …

New pathological and clinical insights in endometrial cancer in view of the updated ESGO/ESTRO/ESP guidelines

A Santoro, G Angelico, A Travaglino, F Inzani… - Cancers, 2021 - mdpi.com
Simple Summary Histopathological classification of endometrial carcinoma has evidenced
two main groups with different biological behavior: low-grade (G1–G2) and high-grade (G3) …

Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups

T Bosse, RA Nout, JN McAlpine… - The American journal …, 2018 - journals.lww.com
Our aim was to investigate whether molecular classification can be used to refine prognosis
in grade 3 endometrial endometrioid carcinomas (EECs). Grade 3 EECs were classified into …